Business Description
Ectin Research AB
ISIN : SE0015987714
Compare
Compare
Traded in other countries / regions
ECTIN B.Sweden IPO Date
2021-08-18Description
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.16 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -215.9 | |||||
3-Year EPS without NRI Growth Rate | -145.6 | |||||
3-Year Book Growth Rate | -26.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.16 | |||||
9-Day RSI | 42.11 | |||||
14-Day RSI | 40.96 | |||||
6-1 Month Momentum % | -69.9 | |||||
12-1 Month Momentum % | -63.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 2.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.87 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -146.58 | |||||
ROA % | -123.28 | |||||
ROIC % | -129.81 | |||||
ROC (Joel Greenblatt) % | -150758.93 | |||||
ROCE % | -137.57 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.45 | |||||
Price-to-Tangible-Book | 0.45 | |||||
EV-to-EBIT | 0.14 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-FCF | 0.29 | |||||
Price-to-Net-Current-Asset-Value | 0.45 | |||||
Price-to-Net-Cash | 0.62 | |||||
Earnings Yield (Greenblatt) % | 714.29 | |||||
FCF Yield % | -907.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ectin Research AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -1.34 | ||
Beta | 0 | ||
Volatility % | 235.46 | ||
14-Day RSI | 40.96 | ||
14-Day ATR (kr) | 0.062464 | ||
20-Day SMA (kr) | 0.091575 | ||
12-1 Month Momentum % | -63.39 | ||
52-Week Range (kr) | 0.0005 - 1.48 | ||
Shares Outstanding (Mil) | 12.69 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ectin Research AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ectin Research AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Ectin Research AB Frequently Asked Questions
What is Ectin Research AB(XSAT:ECTIN B)'s stock price today?
The current price of XSAT:ECTIN B is kr0.07. The 52 week high of XSAT:ECTIN B is kr1.48 and 52 week low is kr0.00.
When is next earnings date of Ectin Research AB(XSAT:ECTIN B)?
The next earnings date of Ectin Research AB(XSAT:ECTIN B) is 2024-08-27.
Does Ectin Research AB(XSAT:ECTIN B) pay dividends? If so, how much?
Ectin Research AB(XSAT:ECTIN B) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |